FDA Inspection
Corvus Medical, Inc.Corvus Medical, Inc. – FDA Inspection, May 22, 2012
Record Details
This FDA Inspection record concerns Corvus Medical, Inc., with an inspection on May 22, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Corvus Medical, Inc.
- Inspection Date
- May 22, 2012
- Product Type
- Biologics
View Company Profile
ID · 50545df5-706e-44c6-bcaf-173cf86ef971
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 783195
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
4- 21 CFR 1271.290(e)Documenting disposition of each HCT/P
- 21 CFR 1271.180(a)Procedures to meet core CTGP
- 21 CFR 1271.265(f)Return to inventory--procedures
- 21 CFR 1271.320(a)Procedures re complaints
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Corvus Medical, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 23, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 19, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 19, 2013 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Corvus Medical, Inc.
- FDA Inspection 1054910 - 2018-05-23
- FDA Inspection 927866 - 2015-05-19
- FDA Inspection 825199 - 2013-03-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.